Overview on Sclerodermal Renal Crisis
Mahdi Ali M. Alyami *
Tabuk University, KSA.
Jalawi Talal A. Alotaibi
Tabuk University, KSA.
Shahad Saad A. Aljoaid
Tabuk University, KSA.
Tariq Bander F. Alanazi
Tabuk University, KSA.
Waleed Farhan D. Alshammari
Tabuk University, KSA.
Nuwayr Hamdan D. Albalawi
Tabuk University, KSA.
Reema Abdulrahman A. Alanazi
Tabuk University, KSA.
Abrar Ali M. Aldhameen
Immam Abdulrahman Bin Faisal University, Dammam, KSA.
Muflih Abdullah S. Albalawi
Tabuk University, KSA.
Mona Khalid M. Alqubali
Tabuk University, KSA.
Marawn Fahad H. Altemani
King Salman Armed Force Hospital, Tabuk, KSA.
Abeer Abdulrhman. Basmih
AlNoor specialist Hospital, Makkah, Saudi Arabia.
*Author to whom correspondence should be addressed.
Abstract
Usually, malignant high blood pressure and severe renal damage are main characters in SSc. SRCs is a relatively rare condition, found in approximately 5% of all SSc patients. This study was carried out to summarize the contemporary evidence regarding the causes, risk factors, manifestations, management and prognosis of Sclerodermal Renal Crisis. a simple review was carried out, searching databases PubMed, Google Scholar, and EBSCO. The authors extracted the needed data and stated that SRCs continues to be a rare diagnosis affecting up to six percent of SSc patients, but has a high morbidity and death influence. SRCs presentation is varied, with hypertension, normal BP and renal insufficiency. Medics should be minded by potential SRCs presentations. Early detection and initiation of aggressive ACEi antihypertensive medication in ED could enhance patient outcomes and around 60% of SRCs patients need dialysis.
Keywords: Scleroderma, systemic sclerosis, renal crisis